Winai Porntipworawech: The $50 Life-Saving Drug Big Pharma Doesn’t Want You to See
Winai Porntipworawech, Former Vice President of GCME, shared a post on LinkedIn:
“Brazilian scientists at Butantan Institute developed a snake venom-derived drug that dissolves dangerous blood clots within minutes without major side effects.
The medication costs $50 per treatment compared to American alternatives charging more than $5,000 with significant bleeding risks.
The drug uses a modified protein from Brazilian pit viper venom that specifically targets clot-forming proteins.
Unlike American blood thinners that affect entire clotting systems, this medication only dissolves existing dangerous clots.
Patients avoid the bleeding complications that kill thousands yearly from traditional treatments.
It works like targeted demolition rather than carpet bombing.
The pharmaceutical industry resistance reveals priorities.
American drug companies promote expensive blood thinners despite high complication rates and limited effectiveness.
The cheap Brazilian alternative threatens $30 billion in yearly American anticoagulant sales.
Critics argue industry lobbying delays FDA approval despite proven safety in extensive Brazilian trials.
For 795,000 Americans suffering strokes yearly and millions taking blood thinners, this represents lifesaving innovation kept inaccessible.
The current American treatment causes 1 in 100 patients to suffer dangerous bleeding episodes.
Brazilian alternatives prevent both clots and complications while costing 100 times less than American medications.
Should American patients suffer dangerous side effects when Brazilian alternatives prove safer and cheaper?
Source: Butantan Institute and New England Journal of Medicine, February 2025.”
Stay updated with Hemostasis Today.
-
Jul 26, 2026, 16:26Novi Yanti Sari: When MPNs Affect the Heart
-
Jul 26, 2026, 16:21Beyond Drugs: Can Museums Become a Medical Prescription?
-
Jul 26, 2026, 14:45Sarah Giorgia Grazia Giannone: An Exciting Chapter in Gene Therapy Research
-
Jul 26, 2026, 14:21Javed Anees: Cerebral Collateral Circulation in Acute Ischemic Stroke
-
Jul 26, 2026, 14:11André Picard։ Canadian Blood Supplies Drop Sharply, Urgent Donor Appeal Issued
-
Jul 26, 2026, 13:54Lorenzo Scalia: New Review Highlights Anticoagulant Strategies for Elderly Patients With Atrial Fibrillation
-
Jul 26, 2026, 13:32Ahmed Kotb: A Practical Guide to Von Willebrand Disease
-
Jul 26, 2026, 12:42Emmanuel J Favaloro: Celebrating Excellence in Scientific Peer Review
-
Jul 26, 2026, 12:20Advancing Sickle Cell Care Through Advocacy – American Society of Hematology